Skip to Content

Rebif RebiDose

In the US, Rebif RebiDose (interferon beta-1a systemic) is a member of the drug class interferons and is used to treat Multiple Sclerosis and Neuritis.

US matches:

Ingredient matches for Rebif RebiDose

Interferon Beta-1A

Interferon Beta-1a is reported as an ingredient of Rebif RebiDose in the following countries:

  • Switzerland

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.